Exlites Holdings International, Inc. (EXHI)

USD 0.3

(0.0%)

EBITDA Summary of Exlites Holdings International, Inc.

  • Exlites Holdings International, Inc.'s latest annual EBITDA in 2023 was -90.49 Thousand USD , up 95.47% from previous year.
  • Exlites Holdings International, Inc.'s latest quarterly EBITDA in 2024 Q1 was -15.88 Thousand USD , down 0.0% from previous quarter.
  • Exlites Holdings International, Inc. reported an annual EBITDA of -341.83 Thousand USD in 2022, down 0.0% from previous year.
  • Exlites Holdings International, Inc. reported an annual EBITDA of - USD in 2015, up 100.0% from previous year.
  • Exlites Holdings International, Inc. reported a quarterly EBITDA of -2059.00 USD for 2024 Q2, up 87.04% from previous quarter.
  • Exlites Holdings International, Inc. reported a quarterly EBITDA of 6350.00 USD for 2023 Q1, down 0.0% from previous quarter.

Annual EBITDA Chart of Exlites Holdings International, Inc. (2023 - 1993)

Historical Annual EBITDA of Exlites Holdings International, Inc. (2023 - 1993)

Year EBITDA EBITDA Growth
2023 -90.49 Thousand USD 95.47%
2022 -341.83 Thousand USD 0.0%
2015 - USD 100.0%
2014 - USD 0.0%
1997 -200 Thousand USD -111.11%
1996 1.8 Million USD 194.74%
1995 -1.9 Million USD -18.75%
1994 -1.6 Million USD -300.0%
1993 -400 Thousand USD 0.0%

Peer EBITDA Comparison of Exlites Holdings International, Inc.

Name EBITDA EBITDA Difference
China Medicine Corporation 13.27 Million USD 100.682%
DH Enchantment Inc. -145.23 Thousand USD 37.69%
Itonis, Inc. -38.31 Thousand USD -136.212%
One Step Vending Corp. -26.55 Thousand USD -240.814%
MediPal Holdings Corporation 431.52 Million USD 100.021%
PD-Rx Pharmaceuticals, Inc. -51.41 Thousand USD -75.991%
Pharmagen, Inc. -2.89 Million USD 96.873%
Suzuken Co., Ltd. 340.78 Million USD 100.027%